OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Obstetrics and Gynecology is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
The data needed to leave no woman behind	420
SMFM Divider Page	293
Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: response	266
Hospital variation in responses to safety warnings about power morcellation in hysterectomy	260
1044 Modifiable factors in the treatment of severe postpartum hypertension	215
1061 Experiences of discrimination in low-income pregnant women	196
1059 Examining the association of antepartum anemia on cesarean morbidity	183
1092 Blood pressure pattern pre-pregnancy through 42-day postpartum of women with preeclampsia, gestational, and chronic hypertension	173
1067 Electronic FHR monitoring, pH and newborn outcomes – this is as good as it gets	169
1080 Mechanical cervical ripening after rupture of membranes and risk of chorioamnionitis: systematic review and meta-analysis	166
1108 Balloon tamponade versus a novel vacuum-induced hemorrhage control device for treatment of postpartum uterine bleeding	162
1105 Edinburgh postnatal depression scores and postpartum healthcare utilization	161
1051 Preeclampsia prevention with 81mg versus 162mg of aspirin prophylaxis based upon timing of initiation	157
1047 Placenta accreta spectrum in IVF pregnancies	148
1057 Pregnancies treated with prophylactic low dose aspirin: a dose dependent comparison of obstetric outcomes	140
1015 Cesarean delivery rates by hospital type among nulliparous and multiparous patients	139
1088 Prenatal diagnosis of TBC1D32-associated disease by exome sequencing: Further evidence of a new syndrome	128
1123 Midtrimester fetal growth restriction as predictor of small for gestational age and adverse obstetrical outcomes	121
1103 Timing of adjunctive azithromycin administration for cesarean prophylaxis and the risk of post-operative infectious morbidity	118
Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size ≤2 cm	115
LB01 Maternal antibody response and placental antibody transfer following asymptomatic and symptomatic SARS-CoV-2 infection	114
150 Management of diabetes in pregnancy during the COVID-19 pandemic at a New York City hospital	108
498 Incidence and risk factors of bladder injury during cesarean delivery	107
838 A comparison of estimated and quantitative blood loss for cesarean and vaginal deliveries	103
1143Escherichia coli antibiotic resistance is driven by antepartum antibiotic exposure	99

832 Does BMI influence the impact of an educational video module on gestational weight gain?	97
1010 Reduction of racial disparities in readmission associated with a standardized postpartum hypertension management protocol	95
575 Effect of visfatin on contractility related gene expression in a human myometrial cell line	90
869 Baseline creatinine decrease does not indicate lower preeclampsia risk in pregnant patients	90
921 How do birth outcomes in black hispanic women compare to other racial/ethnic groups?	83
558 What are the risks of intertwin fetal growth discordance without growth restriction?	81
993 Did health care delivery changes driven by COVID alter pregnancy and postpartum visits?	80
582 Post-cesarean infections before and after implementation of adjunctive azithromycin in addition to standard antibiotics	79
500 Obesity is associated with increased rates of umbilical artery pH< 7.1 at scheduled cesarean delivery	76
926 Aspirin utilization among pregnancies meeting US preventative services task force criteria	75
736 Comparing neonatal outcomes among patients undergoing intravenous glucose tolerance testing for diagnosis of gestational diabetes	75
209 Association of antenatal corticosteroid exposure and infant survival at 22 and 23 weeks	74
546 Natural history of previable and periviable rupture of membranes after treatment of twin-twin transfusion syndrome	73
922 Reduction in cesarean delivery rates following a state collaborative in Maryland	71
906 Does urinary tract dilation (UTD) diagnosis in the 2nd trimester persist in the 3rd trimester?	70
713 Placental histopathology from pregnancies complicated by vasa previa	69
986 Increasing number of scheduled repeat cesarean delivery and adverse outcomes among low-risk individuals	68
729 Placental elasticity imaging: location-informed interpretation may be required for disease state discrimination	67
515 Repurposing of FDA-approved lead drugs as potentiators of uterine contractility in postpartum hemorrhage	67
205 Resolved idiopathic polyhydramnios: does neonatal morbidity resolve?	66
997 The impact of anemia on neonatal outcomes in women with pre-existing diabetes	64
865 Are newborn outcomes different for term babies who were exposed to antenatal corticosteroids?	63
163 Impact of a standardized post-cesarean analgesia regimen on postpartum opioid use	63
860 Risk assessment tool for postpartum readmission due to De-Novo or progressive pregnancy-associated hypertensive disease	62
763 Hemostasis changes among COVID-19 gravidas during SARS-CoV-2 pandemic on rotational thromboelastography	60
553 Distinguishing true from false labor with a novel labor test	59
592 Adverse childhood experiences and preterm birth	59
734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy	59
528 Use of highly effective postpartum contraception by women with opioid use disorder	59
519 Racial/ethnic differences in delivery gestational age and morbidity among women with hypertensive disorders of pregnancy	57
1162 Relationship of maternal-fetal medicine specialist density with maternal mortality ratios between 2010 and 2018	56
742 Disparities in emergency care for underserved women during the first year postpartum	56